Qiming Venture Partners
Edit

Qiming Venture Partners

https://qimingvc.com/
Last activity: 24.05.2024
Active
Invests in categories: ServiceHealthTechTechnologyPlatformMedTechProductDevelopmentDrugResearchProvider
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.

Currently Qiming Venture Partners manages nine US Dollar funds and six RMB funds with $5.9 billion in assets under management. Since our establishment, we have invested in outstanding companies in the TMT and healthcare industries at the early and growth stages.

Since our debut, we have backed over 380 fast-growing and innovative companies. Over 130 companies are already listed on NYSE, NASDAQ, HKEx, Gretai Securities Market, Shanghai Stock Exchange and Shenzhen Stock Exchange, or achieved exit through M&A and other means. There are also over 40 portfolio companies that have achieved unicorn status.

Many of our portfolio companies are today's most influential firms in their respective sectors, including Xiaomi (SEHK:1810), Meituan (SEHK:3690), Bilibili (NASDAQ:BILI, SEHK:9626), Roborock (SHSE:688169), Gan & Lee Pharmaceuticals (SHSE: 603087), Tigermed (SZSE:300347, SEHK:3347), Zai Lab (NASDAQ:ZLAB, SEHK:9688), Venus MedTech (SEHK:2500), CanSino Biologics (SEHK:6185, SHSE:688185), Schrödinger (NASDAQ:SDGR), APT Medical (SHSE:688617), Sanyou Medical (SHSE:688085), New Horizon Health (SEHK:6606), AmoyDx (SZSE:300685), Berry Genomics (SZSE:000710), SinocellTech (SHSE: 688520), WeDoctor Group, and UBTech among many others.
News
483
Portfolio
393
Mentions
76
Location: China, Shanghai
Employees: 51-200
Founded date: 2006
Investment Type: Venture Capital
Investment Stage: Series A; Series B; Series C; Series D

Portfolio 393

DateNameWebsiteTotal RaisedLocation
31.01.2024Synapsorsynapsor.com--
23.01.2024QuantaSingliangzizhige.com-China, Bei...
23.01.2024Structure ...structuretx.com$33MUnited Sta...
23.01.2024Novoprotei...novoprotein.com.cn--
23.01.2024Arrail Gro...arrailgroup.com--
23.01.2024Tuhu.comtuhu.cn$100MChina, Min...
20.01.2024one-chipone-chip.com-China, Jia...
20.01.2024Prismlabprismlab.cn--
20.01.2024M20 Genomi...m20genomics.com--
20.01.2024BlockVisio...blockvision.org$5MSingapore
Show more

News 483

DateTitleDescription
17.11.2023Clinical Proteomics Startup Complete Omics Inc. Successfully Completes Series A Financing, Exclusively Invested by Qiming Venture Partners-
11.11.2023Qiming Monthly Newsletter (October 2023)-
26.10.2023Innovation and Technology Venture Fund adds two co-investment partners-
17.10.2023Qiming Monthly Newsletter (September 2023)-
29.09.2023Qiming Venture Partners' Portfolio Company Tuhu Car Successfully Listed on the Hong Kong Stock Exchange-
06.09.2023Qiming Monthly Newsletter (July 2023)-
06.09.2023Qiming Monthly Newsletter (August 2023)-
31.08.2023Epigenic Therapeutics Announces $32M in Series A Funding-
18.08.2023July 2023 Qiming Newsletter-
30.07.2023Qiming Venture Partners Appoints James Shen as Venture Partner-
Show more

Mentions in press and media 76

DateTitleDescription
24.05.2024Revolutionizing Addiction Treatment: Boulder Care's $35M Funding BoostBoulder Care, a trailblazer in telehealth addiction treatment, secures a game-changing $35 million Series C funding round to expand its reach and impact. With a focus on underserved communities, Boulder Care's innovative approach is set to ...
24.05.2024Boulder Care Secures $35M to Expand Telehealth Addiction Treatment for Underserved CommunitiesWhat You Should Know: – Boulder Care, a leading provider of high-quality addiction treatment, announced today the successful closing of an oversubscribed $35M Series C funding round led by Advance Venture Partners (AVP), joined by Stripes a...
24.05.2024China Digest: Qiming names managing partner; PhiGent raises $30mQiming Venture Partners has promoted Alex Zhou as a managing partner to spearhead investments in frontier technologies. Separately, autonomous driving solutions developer PhiGent Robotics has secured $30 million in a Series Pre-B funding ro...
23.05.2024Qiming Venture Partners Promotes Alex Zhou to Managing PartnerSHANGHAI, May 23, 2024 /PRNewswire/ -- Qiming Venture Partners, a global-leading venture capital firm, is pleased to announce the promotion of Alex Zhou to Managing Partner. As a Qiming home-grown Managing Partner, Alex first joined the fir...
30.08.2023Epigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome Medicine to Clinical DevelopmentSHANGHAI, Aug. 30, 2023 /PRNewswire/ -- Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy utilizing epigenome regulation to treat prevalent diseases, today announced that ...
20.07.2023China's OpenAI Competitor Zhipu AI Receives Funding From Food Delivery Giant MeituanJace Dela Cruz, Tech Times 20 July 2023, 07:07 am China's OpenAI challenger, Zhipu AI, has secured funding from the renowned food delivery giant Meituan, which currently has a market cap of approximately $100 billion. As reported in busines...
19.07.2023China’s OpenAI challenger Zhipu AI gets Meituan fundingZhipu AI, one of China’s most promising challengers to OpenAI, has received funding from the country’s food delivery giant Meituan, which has a market cap of around $100 billion at the time of writing. An affiliate of Zhipu AI recently adde...
15.06.2023Qiming Venture Partners fosters life science, medical and healthcare talent development First healthcare catalyst program starts recruiting in Hong Kong universitiesSHANGHAI and HONG KONG, June 15, 2023 /PRNewswire/ -- Qiming Venture Partners ("Qiming") today launched its first "Catalyst: Qiming Healthcare Summer Program 2023" for universities in Hong Kong, fostering talent developm...
06.06.2023LTZ Announces over $10 Million Pre-A+ Financing led by Qiming Venture Partners-
03.03.2023TandemAI Raises $35 Million in Series A Financing Led by Qiming Venture Partners-
Show more

Reviews 0

Sign up to leave a review

Sign up Log In